-

WIDEOPENWEST MERGER INVESTIGATION: Kaskela Law LLC is Investigating the Proposed Buyout of WideOpenWest, Inc. (NYSE: WOW) Shareholders at $5.20 Per Share; Is the Offer High Enough?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced proposed buyout of WideOpenWest, Inc. (NYSE: WOW) shareholders to determine whether the buyout price is insufficiently low.

Click here to submit your information and receive additional information about this investigation: https://kaskelalaw.com/case/wideopenwest/

On August 11, 2025, WideOpenWest announced that it had agreed to be acquired by private equity firms DigitalBridge Investments and Crestview Partners at a price of $5.20 per share in cash. Following the closing of the proposed transaction, WideOpenWest’s shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether WideOpenWest’s investors will be receiving adequate monetary consideration for their shares, and whether the company’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to the buyout price. Notably, at the time the proposed shareholder buyout was announced, at least one stock analyst was maintaining a price target for WideOpenWest’s shares of $6.50 per share – approximately 25% higher than the buyout price.

WideOpenWest shareholders who believe the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their no-cost legal rights and options at (484) 229 – 0750, or by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/wideopenwest/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation (meaning the firm’s clients are never responsible for any legal costs or expenses). For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:WOW

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom